Mostrar el registro sencillo del ítem

dc.contributor.authorGros, Beatriz
dc.contributor.authorGómez Pérez, Alberto
dc.contributor.authorPleguezuelo, María
dc.contributor.authorSerrano Ruiz, Francisco Javier
dc.contributor.authorSerrano Ruiz, Francisco Javier
dc.contributor.authorde la Mata, Manuel
dc.contributor.authorRodríguez-Perálvarez, Manuel
dc.date.accessioned2023-02-02T12:01:58Z
dc.date.available2023-02-02T12:01:58Z
dc.date.issued2023
dc.identifier.urihttp://hdl.handle.net/10396/24609
dc.description.abstractHelicobacter species may cause chronic inflammation of the biliary tract, but its relationship with cancer is controversial. We performed a systematic review and meta-analysis to evaluate the association between Helicobacter species and hepatobiliary tract malignancies. Twenty-six studies (4083 patients) were included in qualitative synthesis, and 18 studies (n = 1895 qualified for meta-analysis. All studies were at high-intermediate risk of bias. Most studies combined several direct microbiological methods, mostly PCR (23 studies), culture (8 studies), and/or CLOtest (5 studies). Different specimens alone or in combination were investigated, most frequently bile (16 studies), serum (7 studies), liver/biliary tissue (8 studies), and gastric tissue (3 studies). Patients with Helicobacter species infection had an increased risk of hepatobiliary tract malignancies (OR = 3.61 [95% CI 2.18–6.00]; p < 0.0001), with high heterogeneity in the analysis (I2 = 61%; p = 0.0003). This effect was consistent when Helicobacter was assessed in bile (OR = 3.57 [95% CI 1.73–7.39]; p = 0.0006), gastric tissue (OR = 42.63 [95% CI 5.25–346.24]; p = 0.0004), liver/biliary tissue (OR = 4.92 [95% CI 1.90–12.76]; p = 0.001) and serum (OR = 1.38 [95% CI 1.00–1.90]; p = 0.05). Heterogeneity was reduced in these sub-analyses (I2 = 0–27%; p = ns), except for liver/biliary tissue (I2 = 57%; p = 0.02). In conclusion, based on low-certainty data, Helicobacter species chronic infection is associated with a tripled risk of hepatobiliary tract malignancy. Prospective studies are required to delineate public health interventions.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightshttps://creativecommons.org/licenses/by/4.0/es_ES
dc.sourceCancers, 15(3), 595 (2023)es_ES
dc.subjectHelicobacteres_ES
dc.subjectCholangiocarcinomaes_ES
dc.subjectCanceres_ES
dc.subjectNeoplasmses_ES
dc.titleHelicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.3390/cancers15030595es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem